Health & Food
Qsymia weight-loss drug approved by FDA
WASHINGTON (KABC) -- A new prescription drug to fight obesity has been approved by the Food and Drug Administration.
The pill, called Qsymia, is designed for those who are overweight and have at least one weight-related condition, such as high blood pressure or diabetes. It is expected to help them lose 10 percent of their weight, in combination with diet and exercise.
The drug was previously known as Qnexa. The FDA rejected it two years ago because of fears over increased heart rate and birth defects.
It was approved after the manufacturer began a risk management program, controlling its use.
Qsymia is a combination of two FDA-approved drugs, phentermine and topiramate, which have been known to help with weight loss. Phentermine is indicated for short-term weight loss in overweight or obese adults who are exercising and eating a reduced-calorie diet. Topiramate is an anticonvulsant that makes people feel more satisfied after eating.
The drug's maker, Vivus Inc., said it plans to bring the drug to market in the fourth quarter of this year. It hasn't yet decided what the pills will cost.
The Associated Press contributed to this report.
health, health care, obesity, fda, health & food
- Missing plane sent satellite signals for hours
- Jet aborts takeoff after gear failure in Pa.
- 'Flasher' suspect sought for exposure in OC
- LAPD Officer Lee honored at funeral service
- Stalking arrest in WeHo murder-for-hire case 42 min ago
- Inmate escapes jail hours after sentencing
- Norwood pleads not guilty to weapons charge
- OC high-speed chase ends in police shooting
- SXSW continues in Austin after crash kills 2
- NYC explosion kills 8; rescuers resume search
- abcnews: Dog's healing effects on 2 wounded vets
- Bail refused for ex-NFL player Darren Sharper
- Amazon hikes Prime membership to $99 per year
- OTRC: Tina Fey talks 'Mean Girls' reunion rumors